Skip to main navigation Skip to search Skip to main content

Remisión de Crohn colónico refractario a corticoides con Infliximab.

Translated title of the contribution: Corticosteroid refractory colonic Crohn disease with successful remission with infliximab
  • Edgar Alva
  • , Jorge Vásquez
  • , Oscar Frisancho
  • , Lidia Mantilla
  • , Alejandro Yábar
  • , Domingo Morales
  • Hospital Nacional Edgardo Rebagliati Martins (HNERM)

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

We review the case of a 14 year old patient complaining of 5 months of bloody and mucous diarrhea, abdominal pain, fever and 10 kg weight loss. At the beginning she received cotrimoxazole and then chloramphenicol with no success. With the suspicious of tuberculosis she was treated for a month with the corresponding drugs with no clinical improvement. Colonoscopy revealed the presence of punch - like ulcers, deep linear ones cobblestoning and skip lesions. The histological analysis showed severe distortion the colonic mucosa, ulcers, granulation tissue, lymphoid follicles and a trend towards the formation of granulomatous lesions. The clinical, endoscopic and histological features were consistent with Crohn disease. The activity index for it was greater than 450. The patient received 60 mg bid hydrocortisone but switched to 20 mg bid methylprednisolone at day 10th. After 10 days and because she was doing worst refractoriness to corticoids was considered and 5 mg / kg Infliximab was started. At the third day of treatment symptoms improved dramatically and one week later was almost asymptomatic. Similar dosage of Infliximab was repeated at weeks 2, 6 and 8. Currently the patient is being treated with 75 mg azathioprine as maintenance therapy.

Translated title of the contributionCorticosteroid refractory colonic Crohn disease with successful remission with infliximab
Original languageSpanish
Pages (from-to)51-54
Number of pages4
JournalRevista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú
Volume29
Issue number1
StatePublished - 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corticosteroid refractory colonic Crohn disease with successful remission with infliximab'. Together they form a unique fingerprint.

Cite this